Denosumab: a new option in the treatment of bone metastases from urological cancers

by Yuasa, Takeshi, Yamamoto, Shinya, Urakami, Shinji, Fukui, Iwao, Yonese, Junji
Published 2012

Phase-1 study of abiraterone acetate in chemotherapy-naïve Japanese patients with castration-resistant prostate cancer

by Matsubara, Nobuaki, Uemura, Hiroji, Fukui, Iwao, Niwakawa, Masashi, Yamaguchi, Akito, Iizuka, Koho, Akaza, Hideyuki
Published 2014

Prior administration of a non-steroidal anti-androgen failed to prevent the flare-up caused by a luteinizing hormone-releasing hormone agonist in a patient with metastatic prostate...

by Uehara, Sho, Yuasa, Takeshi, Fujii, Yasuhisa, Yano, Akihiro, Yamamoto, Shinya, Masuda, Hitoshi, Fukui, Iwao, Yonese, Junji
Published 2015

Long-term complete response of antiandrogen withdrawal syndrome in a patient with metastatic prostate cancer: A case report

by Sano, Masayuki, Yamamoto, Shinya, Uehara, Sho, Yuasa, Takeshi, Masuda, Hitoshi, Fukui, Iwao, Yonese, Junji
Published 2016

Improvement of renal function by changing the bone-modifying agent from zoledronic acid to denosumab

by Yamasaki, Mutsushi, Yuasa, Takeshi, Uehara, Sho, Fujii, Yasuhisa, Yamamoto, Shinya, Masuda, Hitoshi, Fukui, Iwao, Yonese, Junji
Published 2016

Longitudinal change in health-related quality of life after intensity-modulated radiation monotherapy for clinically localized prostate cancer

by Yamamoto, Shinya, Fujii, Yasuhisa, Masuda, Hitoshi, Urakami, Shinji, Saito, Kazutaka, Kozuka, Takuyo, Oguchi, Masahiko, Fukui, Iwao, Yonese, Junji
Published 2013

Clinical outcome of patients with pancreatic metastases from renal cell cancer

by Yuasa, Takeshi, Inoshita, Naoko, Saiura, Akio, Yamamoto, Shinya, Urakami, Shinji, Masuda, Hitoshi, Fujii, Yasuhisa, Fukui, Iwao, Ishikawa, Yuichi, Yonese, Junji
Published 2015